Announce Date | 02/26/2025 |
EPS Normalized Actual | $2.78 (Beat by $0.17) |
EPS GAAP Actual | $2.78 (Beat by $0.17) |
Revenue Actual | $9.993B |
Revenue Surprise | Beat by $9993M |
Announce Date | 12/31/1969 (Pre-Market) |
EPS Normalized Estimate | $ |
EPS GAAP Estimate | $ |
Revenue Estimate | $0B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Jan 2030 | 17.15 | 14.23 | 16.80412 | 17.83368 | 2 |
Jan 2029 | 16.79 | 14.54 | 16.23777 | 17.32777 | 4 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ1 2025 (Jan 2025) | 1.78 | 1.78 | 9.993B | 7.06% | 9993M |
FQ4 2024 (Oct 2024) | 1.58 | 1.58 | 9.444B | 7.67% | 9444M |
FQ3 2024 (Jul 2024) | 1.48 | 1.48 | 9.325B | 7.74% | 9325M |
FQ2 2024 (Apr 2024) | 1.58 | 1.58 | 9.133B | 9.7% | 9133M |
FQ1 2024 (Jan 2024) | 1.47 | 1.47 | 9.287B | -237.59% | 9287M |
FQ4 2023 (Oct 2023) | 1.26 | 1.26 | 8.72B | 10.13% | 8720M |
FQ3 2023 (Jul 2023) | 1.3 | 1.3 | 8.603B | 10.26% | 8603M |
FQ2 2023 (Apr 2023) | 0.2 | 0.2 | 8.247B | 100% | 8247M |
FQ4 Announce Date
12/31/1969 (Pre-Market)
Consensus EPS Estimates
Consensus Revenue Estimates
0B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2027 (Oct 2027) | 3.60847 | -- | 3.59692 | 3.66429 | 23 |
FQ3 2027 (Jul 2027) | 3.51438 | -- | 3.50313 | 3.56874 | 20 |
FQ2 2027 (Apr 2027) | 3.29634 | -- | 3.28714 | 3.31755 | 23 |
FQ1 2027 (Jan 2027) | 3.40395 | -- | 3.35092 | 3.63642 | 16 |
FQ4 2026 (Oct 2026) | 3.30047 | -- | 3.26642 | 3.34084 | 13 |
FQ3 2026 (Jul 2026) | 3.20431 | -- | 3.17125 | 3.2435 | 11 |
FQ2 2026 (Apr 2026) | 3.0925 | -- | 3.0606 | 3.13032 | 13 |
FQ1 2026 (Jan 2026) | 3.00238 | 40.71 | 2.95561 | 3.20743 | 11 |
FQ4 2025 (Oct 2025) | 2.78735 | 43.32 | 2.75859 | 2.82144 | 22 |
FQ3 2025 (Jul 2025) | 2.72445 | 45.68 | 2.69634 | 2.75777 | 12 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2027 (Oct 2027) | 12.23B | -- | 12.2B | 12.38B | 19 |
FQ3 2027 (Jul 2027) | 12.03B | -- | 12B | 12.17B | 19 |
FQ2 2027 (Apr 2027) | 11.7B | -- | 11.68B | 11.76B | 18 |
FQ1 2027 (Jan 2027) | 12.01B | -- | 11.86B | 12.64B | 17 |
FQ4 2026 (Oct 2026) | 11.66B | -- | 11.57B | 11.77B | 14 |
FQ3 2026 (Jul 2026) | 11.53B | -- | 11.44B | 11.64B | 12 |
FQ2 2026 (Apr 2026) | 11.18B | -- | 11.09B | 11.29B | 14 |
FQ1 2026 (Jan 2026) | 10.97B | 8.91 | 10.84B | 11.55B | 12 |
FQ4 2025 (Oct 2025) | 10.71B | 11.84 | 10.63B | 10.81B | 21 |
FQ3 2025 (Jul 2025) | 10.54B | 11.52 | 10.46B | 10.64B | 11 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
8
EPS # of Misses
0
EPS # of in-lines
0
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2025 (Jan 2025) | 1.78 | 1.78 | 100% | |
FQ4 2024 (Oct 2024) | 1.58 | 1.58 | 100% | |
FQ3 2024 (Jul 2024) | 1.48 | 1.48 | 100% | |
FQ2 2024 (Apr 2024) | 1.58 | 1.58 | 100% | |
FQ1 2024 (Jan 2024) | 1.47 | 1.47 | 100% | |
FQ4 2023 (Oct 2023) | 1.26 | 1.26 | 100% | |
FQ3 2023 (Jul 2023) | 1.3 | 1.3 | 100% | |
FQ2 2023 (Apr 2023) | 0.2 | 0.2 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2025 (Jan 2025) | $0B | $9.99B | $9993M | 100% |
FQ4 2024 (Oct 2024) | $0B | $9.44B | $9444M | 100% |
FQ3 2024 (Jul 2024) | $0B | $9.33B | $9325M | 100% |
FQ2 2024 (Apr 2024) | $0B | $9.13B | $9133M | 100% |
FQ1 2024 (Jan 2024) | $0B | $9.29B | $9287M | 100% |
FQ4 2023 (Oct 2023) | $0B | $8.72B | $8720M | 100% |
FQ3 2023 (Jul 2023) | $0B | $8.6B | $8603M | 100% |
FQ2 2023 (Apr 2023) | $0B | $8.25B | $8247M | 100% |